How One Mother Was Forced to Abandon Her Legal Career Over Her Daughter's Deadly Food Allergies

A Mother's Impossible Choice: Career or Child Safety

When Katy, a practicing lawyer from Cornwall, weighed up returning to work after maternity leave, most mothers face the usual juggling act of childcare and career. But Katy's decision was driven by something far more serious — a genuine fear that her five-year-old daughter Molly could die if left in anyone else's care.

Facing what she describes as the "horrific ongoing stress" of managing her daughter's life-threatening food allergies, Katy ultimately walked away from her legal career, cutting her family's household income in half.

A Holiday Nightmare That Changed Everything

The turning point came during a family trip to Italy when Molly was just one year old. Despite Katy carefully explaining her daughter's allergies to restaurant staff — both in conversation and through written translation cards — Molly suffered a severe anaphylactic reaction after eating a restaurant meal.

"She started getting really lethargic, then just went floppy," Katy recalled. "We were terrified. We just ran through the streets trying to get back to the hotel."

Katy described it as "the worst experience" of both her and her husband's lives. She administered an adrenaline pen on the spot, and Molly was rushed to hospital, where she eventually recovered. But the fear that took hold that night never loosened its grip.

Almost exactly a year later, history repeated itself — this time on home soil in England, when Molly consumed a muffin that contained milk. It was after this second serious reaction that Katy made the decision to step away from law entirely, acknowledging that she simply did not trust anyone else to keep her daughter safe.

The Allergy Crisis Facing Families Across England

Katy's story is far from isolated. Food allergy rates in England are estimated to have doubled in the decade leading up to 2018, according to a major study published in The Lancet in 2024. The steepest increase has been recorded among children under five, with approximately 4% now affected.

Emergency hospital admissions linked to food-related anaphylaxis also doubled over the 20 years to 2024, reaching 1,709 recorded cases — a figure that underscores what experts are calling a growing public health emergency.

Professor Adam Fox, a specialist in paediatric allergy, has stated that allergies now carry "major public health implications for millions of people" and that the medical community can no longer treat the issue as a niche concern.

The Fight for NHS Access to Immunotherapy

Doctors, patient groups, and charities are increasingly calling for broader NHS access to a treatment known as food oral immunotherapy (OIT). The process involves patients consuming tiny, carefully measured quantities of their allergen under strict medical supervision, with dosages gradually increased over time to build immune tolerance.

While OIT is available privately — often at considerable cost — routine NHS access remains extremely limited. The National Allergy Strategy Group is pressing the government to change this, arguing that thousands of families are being left without viable options.

A charity-funded OIT programme currently operates across nine NHS hospitals in England, focusing on peanut and milk allergies using commercially available foods. However, an NHS spokesperson confirmed that OIT is "not routinely available on the NHS due to limited evidence around the effectiveness of available products."

Professor Fox disputes this position, pointing to research from the European Academy of Allergy and Clinical Immunology (EAACI) as sufficient proof of both the safety and efficacy of OIT. He argues the real barrier is not a lack of evidence but a lack of institutional willingness to translate that evidence into accessible treatment.

"The problem is not doing the research," Fox said. "It's for the NHS to put the resource and the organisational will into turning it into something that people actually have access to in a timeframe that would be useful."

A 2025 report by the British Society for Allergy & Clinical Immunology (BSACI) Registry for Immunotherapy further highlighted what it called "unmet need" and "unwarranted variation" in how immunotherapy is provided across the UK.

Waiting Lists, Distance, and Desperation

Katy's own efforts to access OIT for Molly through the NHS have been met with significant obstacles. Though Molly has been referred for milk OIT by her local NHS trust, the family has been told the waiting list stretches to at least two years. The nearest available clinic is nearly 300 miles away in London, and acceptance onto the programme is not guaranteed.

For other Cornwall families, the situation has pushed them toward expensive private treatment. Scott and Louisa from Helston made the difficult decision to seek private OIT for their five-year-old daughter Carey after she experienced a terrifying anaphylactic reaction as a toddler.

Scott described the decision as "a big sacrifice" — not only financially, but in the sheer logistical effort involved. Every visit to their clinic in Hampshire required a round trip of approximately 400 miles.

A Cautious Return to Work

For Katy, there is finally a glimmer of hope. Now that Molly has started school, she says she is beginning to consider re-entering the workforce. Her growing confidence stems from her school's robust allergy policies, as well as the recent government announcement that allergy awareness training will become compulsory in schools across England.

The NHS, for its part, has stated it is "currently supporting a trial to gather more evidence on the use of oral immunotherapy for food allergies, while also developing guidance to support local services to improve allergy care."

For families like Katy's, however, that progress cannot come quickly enough. The human cost — measured not just in medical emergencies, but in careers abandoned, incomes halved, and childhoods lived under constant threat — demands urgent and meaningful action.